The association of obesity and low adiponectin level suggested the possibility of adiponectin acting as a biomarker for metabolic syndrome, especially among perimenopausal and postmenopausal women or the elderly [78,79]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.